Search
for
Sort by
Research 30 of 1000+
- Impact of Cyproterone Acetate and Ethinylestradiol on Clomiphene Resistant PCOS Patient with High Serum AMH level
- REPRODUCTIVE HORMONE LEVELS AND METABOLIC SYNDROME IN WOMEN WITH POLYCYSTIC OVARY SYNDROME IN SANA'A, YEMEN
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Gonadal Function in Men with Cushing Syndrome
- Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women
- Tackling polycystic ovary syndrome
- Targets to treat androgen excess in polycystic ovary syndrome
- Pathophysiology and Complications of Polycystic Ovary Syndrome (PCOS): A Stepwise Visual Infographic
- Clinico-biochemical characteristics of 229 Portuguese infertile women with polycystic ovary syndrome: clinical relevance and relationship with fertility treatment results
- Clinical efficacy and safety of low‐dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism
- Metastatic Embryonal Cell Carcinoma with High Testosterone and Absence of Secondary Sexual Characteristics
- Protective Effect of “ <i>Ark‐e‐Kasni</i> ,” a Unani Formulation, in Letrozole and High‐Fat Diet–Induced Polycystic Ovarian Syndrome in Rats
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Hormonal profile and efficacy of long pulse Nd-YAG laser in treatment of hirsutism.
- Evaluation the levels of some hormones in women with polycystic ovary syndrome
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- SAT-288 Successful Virilization of a PAIS Patient with a Missense Mutation In The Ligand-binding Domain Of The Androgen Receptor with Combined High-dose Testosterone and Aromatase Inhibitor
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study
- Effects of Abuse of Anabolic Androgenic Steroids on Iraqi Athletes
- POLYCYSTIC OVARY SYNDROME: PATHOGENESIS, TREATMENT AND SECONDARY ASSOCIATED DISEASES
- Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
- Hormonal profile in Indian men with premature androgenetic alopecia
- Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review
- PMON325 Rare Presentation of Precocious Puberty Secondary to LH-Secreting Adenoma
- Androgen Profiling by Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age